JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sarkar, M.
Right arrow Articles by Odegard, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sarkar, M.
Right arrow Articles by Odegard, K. C.

Anesth Analg 2005;101:645-650
© 2005 International Anesthesia Research Society
doi: 10.1213/01.ane.0000166764.99863.b4

PEDIATRIC ANESTHESIA

Hemodynamic Responses to Etomidate on Induction of Anesthesia in Pediatric Patients

Molly Sarkar, MD, PhD*, Peter C. Laussen, MBBS*, David Zurakowski, PhD{dagger}, Avinash Shukla, MD*, Barry Kussman, MBBS*, and Kirsten C. Odegard, MD*

Departments of *Anesthesia and {dagger}Orthopaedic Surgery, Children’s Hospital, Harvard Medical School, Boston, Massachusetts

Address correspondence and reprint requests to Kirsten C. Odegard, MD, Cardiac Anesthesia Service, Children’s Hospital, 300 Longwood Avenue, Boston, MA 02115. Address electronic mail to: kirsten.odegard{at}childrens.harvard.edu.

Etomidate is often used for inducing anesthesia in patients who have limited hemodynamic reserve. Using invasive hemodynamic monitoring, we studied the acute effects of a bolus of etomidate during induction of anesthesia in children. Twelve children undergoing cardiac catheterization were studied (mean age, 9.2 ± 4.8 yr; mean weight, 33.4 ± 15.4 kg); catheterization procedures included device closure of secundum atrial septal defects (n = 7) and radiofrequency catheter ablation procedures for supraventricular tachycardia (n = 5). Using IV sedation, a balloon-tipped pulmonary artery catheter was placed to measure intracardiac and pulmonary artery pressures and oxygen saturations. Baseline measurements were recorded and then re-peated after a bolus of IV etomidate (0.3 mg/kg). For the entire group, no significant changes in right atrial, aortic, or pulmonary artery pressure, oxygen saturations, calculated Qp:Qs ratio or systemic or pulmonary vascular resistance were detected after the bolus dose of etomidate. The lack of clinically significant hemodynamic changes after etomidate administration supports the clinical impression that etomidate is safe in children. Further research is needed to determine the hemodynamic profile of etomidate in neonates and in pediatric patients with severe ventricular dysfunction and pulmonary hypertension.




This article has been cited by other articles:


Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
K. Subramaniam and J.-P. Yared
Management of Pulmonary Hypertension in the Operating Room
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2007; 11(2): 119 - 136.
[Abstract] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2005 by the International Anesthesia Research Society.